Literature DB >> 17620421

Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.

Maria Kolak1, Jukka Westerbacka, Vidya R Velagapudi, Dick Wågsäter, Laxman Yetukuri, Janne Makkonen, Aila Rissanen, Anna-Maija Häkkinen, Monica Lindell, Robert Bergholm, Anders Hamsten, Per Eriksson, Rachel M Fisher, Matej Oresic, Hannele Yki-Järvinen.   

Abstract

OBJECTIVE: We sought to determine whether adipose tissue is inflamed in individuals with increased liver fat (LFAT) independently of obesity. RESEARCH DESIGN AND METHODS: A total of 20 nondiabetic, healthy, obese women were divided into normal and high LFAT groups based on their median LFAT level (2.3 +/- 0.3 vs. 14.4 +/- 2.9%). Surgical subcutaneous adipose tissue biopsies were studied using quantitative PCR, immunohistochemistry, and a lipidomics approach to search for putative mediators of insulin resistance and inflammation. The groups were matched for age and BMI. The high LFAT group had increased insulin (P = 0.0025) and lower HDL cholesterol (P = 0.02) concentrations.
RESULTS: Expression levels of the macrophage marker CD68, the chemokines monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha, and plasminogen activator inhibitor-1 were significantly increased, and those of peroxisome proliferator-activated receptor-gamma and adiponectin decreased in the high LFAT group. CD68 expression correlated with the number of macrophages and crown-like structures (multiple macrophages fused around dead adipocytes). Concentrations of 154 lipid species in adipose tissue revealed several differences between the groups, with the most striking being increased concentrations of triacylglycerols, particularly long chain, and ceramides, specifically Cer(d18:1/24:1) (P = 0.01), in the high LFAT group. Expression of sphingomyelinases SMPD1 and SMPD3 were also significantly increased in the high compared with normal LFAT group.
CONCLUSIONS: Adipose tissue is infiltrated with macrophages, and its content of long-chain triacylglycerols and ceramides is increased in subjects with increased LFAT compared with equally obese subjects with normal LFAT content. Ceramides or their metabolites could contribute to adverse effects of long-chain fatty acids on insulin resistance and inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620421     DOI: 10.2337/db07-0111

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  130 in total

Review 1.  Adipose tissue remodeling in pathophysiology of obesity.

Authors:  Mi-Jeong Lee; Yuanyuan Wu; Susan K Fried
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

2.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

Review 3.  Lipidomics as a tool for the study of lipoprotein metabolism.

Authors:  Anatol Kontush; M John Chapman
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

4.  Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stress.

Authors:  Akiko Eguchi; Milos Lazic; Aaron M Armando; Susan A Phillips; Roia Katebian; Spyridoula Maraka; Oswald Quehenberger; Dorothy D Sears; Ariel E Feldstein
Journal:  J Mol Med (Berl)       Date:  2016-07-09       Impact factor: 4.599

Review 5.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 6.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

7.  Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity.

Authors:  Nicole H Rogers; James W Perfield; Katherine J Strissel; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

8.  Ceramides and glucosylceramides are independent antagonists of insulin signaling.

Authors:  Jose A Chavez; M Mobin Siddique; Siew Tein Wang; Jianhong Ching; James A Shayman; Scott A Summers
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

Review 9.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

10.  Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects.

Authors:  Caroline M Apovian; Sherman Bigornia; Melanie Mott; Melissa R Meyers; Jagadish Ulloor; Manana Gagua; Marie McDonnell; Donald Hess; Lija Joseph; Noyan Gokce
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.